Originally Posted by
skywatch
So what is the point of the additional data collection then, if the assumption is that this EUA vaccine is the same as any other normally approved vaccine? is it that the current group of individuals getting vaccinated are akin to test subjects to gather more data points?
Assumptions don't keep bureaucrats employed, they still have to dot the I's and cross the T's. But for any informed industry observer it's fairly obvious at this point that things are going very well.
Phase 4 always monitors the real-world deployment of pharma, but phase 4 is normally after regular certification. In this case it will inform the regular approval process.